12-step participation as a pathway to recovery: the Maryhaven experience and implications for treatment and research

G. S. BRIGHAM | 2003
Périodique

Maryhaven, a comprehensive, community-based drug abuse treatment facility, combines a core commitment to 12-step principles and practices with the use of scientifically derived treatment interventions. Treatment goals at Maryhaven include abstin[...]

Plus d'info

Ajouter à la sélection

Addressing smoking in community drug abuse treatment programs: practical and policy considerations

G. S. BRIGHAM ; G. SCHROEDER ; E. SCHINDLER | 2007
Dans Journal of Psychoactive Drugs (Vol.39 n°4, 2007) Article : Périodique

ENGLISH : Smoking is the leading cause of preventable death in the United States. This public health problem is of particular concern among individuals with substance use disorders in that they smoke at a greater rate than the general public. [...]

Plus d'info

Ajouter à la sélection

Using buprenorphine short-term taper to facilitate early treatment engagement

G. S. BRIGHAM ; L. AMASS ; T. WINHUSEN ; J. M. HARRER ; A. PELT | 2007
Dans Journal of Substance Abuse Treatment (Vol.32, n°4, June 2007) Article : Périodique

The U.S. Federal Food and Drug Administration approved buprenorphine for drug abuse treatment in 2002, and it became available for clinical use in early 2003. Maryhaven, a community treatment program, participated in a National Institute on Drug[...]

Plus d'info

Ajouter à la sélection